Michael D. Pak

Array ( [id] => 6588643 [patent_doc_number] => 20100061986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Chronic Rejection Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/524041 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12251 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061986.pdf [firstpage_image] =>[orig_patent_app_number] => 12524041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588643 [patent_doc_number] => 20100061986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Chronic Rejection Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/524041 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12251 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061986.pdf [firstpage_image] =>[orig_patent_app_number] => 12524041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588643 [patent_doc_number] => 20100061986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Chronic Rejection Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/524041 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12251 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061986.pdf [firstpage_image] =>[orig_patent_app_number] => 12524041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740817 [patent_doc_number] => 20080234470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'KCNB: A NOVEL POTASSIUM CHANNEL PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/968795 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25547 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234470.pdf [firstpage_image] =>[orig_patent_app_number] => 11968795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11677072 [patent_doc_number] => 09675578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane' [patent_app_type] => utility [patent_app_number] => 12/519126 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 39844 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12519126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682251 [patent_doc_number] => 20080248477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/001395 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 84770 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248477.pdf [firstpage_image] =>[orig_patent_app_number] => 12001395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751885 [patent_doc_number] => 20080159958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'DETERMINATION OF HISTAMINE-3 BIOACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/950560 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8571 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20080159958.pdf [firstpage_image] =>[orig_patent_app_number] => 11950560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588520 [patent_doc_number] => 20100061979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WSITH IMPROVED BIOLOGICAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/515463 [patent_app_country] => US [patent_app_date] => 2007-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 15924 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061979.pdf [firstpage_image] =>[orig_patent_app_number] => 12515463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845490 [patent_doc_number] => 20080181898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Wise/sost nucleic acid sequences and amino acid sequences' [patent_app_type] => utility [patent_app_number] => 11/985836 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 36683 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181898.pdf [firstpage_image] =>[orig_patent_app_number] => 11985836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 356161 [patent_doc_number] => 07488597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-10 [patent_title] => 'Polynucleotide encoding an intracellular estradiol binding protein' [patent_app_type] => utility [patent_app_number] => 11/939001 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11879 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/488/07488597.pdf [firstpage_image] =>[orig_patent_app_number] => 11939001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636310 [patent_doc_number] => 20100035814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'N-Terminal Pegylated Prolactin Receptor Molecules' [patent_app_type] => utility [patent_app_number] => 12/513578 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15751 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035814.pdf [firstpage_image] =>[orig_patent_app_number] => 12513578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431289 [patent_doc_number] => 20100143386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs' [patent_app_type] => utility [patent_app_number] => 12/513413 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7355 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143386.pdf [firstpage_image] =>[orig_patent_app_number] => 12513413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4455512 [patent_doc_number] => 07892756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Human salty taste receptor and methods of modulating salty taste perception' [patent_app_type] => utility [patent_app_number] => 11/875200 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14160 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892756.pdf [firstpage_image] =>[orig_patent_app_number] => 11875200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551813 [patent_doc_number] => 20090285799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Antibody Antagonists of Interleukin-13 Receptor Alpha1' [patent_app_type] => utility [patent_app_number] => 12/445759 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23133 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285799.pdf [firstpage_image] =>[orig_patent_app_number] => 12445759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710298 [patent_doc_number] => 20120003252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'ISOFORMS OF HUMAN SOMATOSTATIN RECEPTOR TYPE 5 PRODUCED BY ALTERNATIVE PROCESSING AND OLIGO-NUCLEOTIDE PAIRS FOR DETECTION THEREOF BY PCR' [patent_app_type] => utility [patent_app_number] => 12/738131 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4731 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12738131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588589 [patent_doc_number] => 20100061983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Method of inhibiting leukocytes with human cxc chemokine receptor 3 antibody' [patent_app_type] => utility [patent_app_number] => 11/903330 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 28441 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061983.pdf [firstpage_image] =>[orig_patent_app_number] => 11903330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9060112 [patent_doc_number] => 08546547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1' [patent_app_type] => utility [patent_app_number] => 12/441478 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 98 [patent_figures_cnt] => 92 [patent_no_of_words] => 14831 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12441478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494316 [patent_doc_number] => 20100009938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID' [patent_app_type] => utility [patent_app_number] => 12/439454 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7201 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009938.pdf [firstpage_image] =>[orig_patent_app_number] => 12439454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228695 [patent_doc_number] => 07601508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Whitefly ecdysone receptor polypeptide and methods' [patent_app_type] => utility [patent_app_number] => 11/840659 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30757 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601508.pdf [firstpage_image] =>[orig_patent_app_number] => 11840659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866292 [patent_doc_number] => 20080145351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Memory influencing protein' [patent_app_type] => utility [patent_app_number] => 11/893723 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9781 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145351.pdf [firstpage_image] =>[orig_patent_app_number] => 11893723 [rel_patent_id] =>[rel_patent_doc_number] =>)